Download Citation
Article Source:
Evocalcet with vitamin D receptor activator treatment for secondary hyperparathyroidism
Shigematsu T,
Asada S,
Endo Y,
Kawata T,
Fukagawa M,
et al.
(2022)
Evocalcet with vitamin D receptor activator treatment for secondary hyperparathyroidism.
PLOS ONE 17(2): e0262829.
https://doi.org/10.1371/journal.pone.0262829